{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:21:12Z","timestamp":1761718872168,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12875-019-1050-4","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T03:02:54Z","timestamp":1575601374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A cluster randomized trial to measure the impact on nonsteroidal anti-inflammatory drug and proton pump inhibitor prescribing in Italy of distributing cost-free paracetamol to osteoarthritic patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Massimo","family":"Vicentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1609-2440","authenticated-orcid":false,"given":"Pamela","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Giorgi Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Di Pede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morena","family":"Pellati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Gandolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Zoboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Ricc\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Busani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"1050_CR1","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington, 2018. Available from \nhttp:\/\/vizhub.healthdata.org\/gbd-compare\n\n. (Accessed Oct 2019)."},{"issue":"10033","key":"1050_CR2","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(16)30002-2","volume":"387","author":"BR Costa da","year":"2016","unstructured":"da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, J\u00fcni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2016;387(10033):2093\u2013105.","journal-title":"Lancet"},{"key":"1050_CR3","unstructured":"NICE clinical guideline 59 Osteoarthritis: the care and management of osteoarthritis in adults. Febbraio 2008. Disponibile al sito: \nhttp:\/\/www.nice.org.uk\/CG059\n\n (ultimo accesso 30\/Sept\/2010)."},{"issue":"2","key":"1050_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain. 2009;10(2):113\u201330.","journal-title":"J Pain"},{"key":"1050_CR5","volume-title":"Assessment and Management of Chronic Pain","author":"ICSI Health Care Guideline","year":"2009","unstructured":"ICSI Health Care Guideline: Assessment and Management of Chronic Pain 2009."},{"key":"1050_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","volume":"57","author":"American Geriatric Society","year":"2009","unstructured":"American Geriatric Society. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57:1331\u201346.","journal-title":"J Am Geriatr Soc"},{"key":"1050_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149\u201358.","journal-title":"Pain"},{"key":"1050_CR8","first-page":"CD004257","volume":"1","author":"TE Towheed","year":"2006","unstructured":"Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006;1:CD004257 Review.","journal-title":"Cochrane Database Syst Rev"},{"key":"1050_CR9","first-page":"1","volume":"1","author":"E Maestri","year":"2010","unstructured":"Maestri E, Formoso G, Giroldini R, Riccomi S, Magrini N, Marata AM. I farmaci nel dolore persistente. Fibromialgia, osteoartrosi, mal di schiena. Pacchetti Informativi sui Farmaci. 2010;1:1\u201316.","journal-title":"Pacchetti Informativi sui Farmaci"},{"issue":"7","key":"1050_CR10","first-page":"524","volume":"24","author":"WS Holt Jr","year":"1992","unstructured":"Holt WS Jr, Mazzuca SA. Prescribing behaviors of family physicians in the treatment of osteoarthritis. Fam Med. 1992;24(7):524\u20137.","journal-title":"Fam Med"},{"key":"1050_CR11","first-page":"CD007017","volume":"5","author":"VL Luiza","year":"2015","unstructured":"Luiza VL, Chaves LA, Silva RM, Emmerick IC, Chaves GC, Fonseca de Ara\u00fajo SC, et al. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines. Cochrane Database Syst Rev. 2015;5:CD007017.","journal-title":"Cochrane Database Syst Rev"},{"key":"1050_CR12","first-page":"CD008654","volume":"8","author":"CJ Green","year":"2010","unstructured":"Green CJ, Maclure M, Fortin PM, Ramsay CR, Aaserud M, Bardal S. Pharmaceutical policies: effects of restrictions on reimbursement. Cochrane Database Syst Rev. 2010;8:CD008654.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1050_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040232","volume":"4","author":"A Fretheim","year":"2007","unstructured":"Fretheim A, H\u00e5velsrud K, MacLennan G, Kristoffersen DT, Oxman AD. The effects of mandatory prescribing of thiazides for newly treated, uncomplicated hypertension: interrupted time-series analysis. PLoS Med. 2007;4(7):e232.","journal-title":"PLoS Med"},{"issue":"3","key":"1050_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/028134301316982379","volume":"19","author":"L Bjerrum","year":"2001","unstructured":"Bjerrum L, Larsen J, Kragstrup J. Guidelines accompanied by changes in reimbursement rules. Effects on lipid-lowering drug prescribing. Scand J Prim Health Care. 2001;19(3):158\u201362.","journal-title":"Scand J Prim Health Care"},{"issue":"17","key":"1050_CR15","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJMsa0803410","volume":"359","author":"CA Jackevicius","year":"2008","unstructured":"Jackevicius CA, Tu JV, Demers V, Melo M, Cox J, Rinfret S, Kalavrouziotis D, Johansen H, Behlouli H, Newman A, Pilote L. Cardiovascular outcomes after a change in prescription policy for clopidogrel. N Engl J Med. 2008;359(17):1802\u201310.","journal-title":"N Engl J Med"},{"issue":"4","key":"1050_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1365-2125.2007.02907.x","volume":"64","author":"S Sakshaug","year":"2007","unstructured":"Sakshaug S, Furu K, Karlstad \u00d8, R\u00f8nning M, Skurtveit S. Switching statins in Norway after new reimbursement policy: a nationwide prescription study. Br J Clin Pharmacol. 2007;64(4):476\u201381.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"1050_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/pds.1664","volume":"17","author":"ML Driel van","year":"2008","unstructured":"van Driel ML, Vander Stichele R, Elseviers M, De Sutter A, De Maeseneer J, Christiaens T. Effects of an evidence report and policies lifting reimbursement restrictions for acid suppressants: analysis of the Belgian national database. Pharmacoepidemiol Drug Saf. 2008;17(11):1113\u201322.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"1050_CR18","doi-asserted-by":"publisher","first-page":"e109915","DOI":"10.1371\/journal.pone.0109915","volume":"9","author":"N Magrini","year":"2014","unstructured":"Magrini N, Formoso G, Capelli O, Maestri E, Nonino F, Paltrinieri B, et al. Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials. PLoS One. 2014;9(10):e109915.","journal-title":"PLoS One"},{"key":"1050_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1472-6963-7-158","volume":"7","author":"N Magrini","year":"2007","unstructured":"Magrini N, Formoso G, Marata AM, Capelli O, Maestri E, Voci C, et al. Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in general practice in Italy. BMC Health Serv Res. 2007;7:158.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/pds.3917","volume":"25","author":"SJ Sinnott","year":"2015","unstructured":"Sinnott SJ, Normand C, Byrne S, Woods N, Whelton H. Copayments for prescription medicines on a public health insurance scheme in Ireland. Pharmaco Epidemiol Drug Saf. 2015;25(6):695\u2013704.","journal-title":"Pharmaco Epidemiol Drug Saf"},{"issue":"1","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/tc.2006.016253","volume":"16","author":"D Twardella","year":"2007","unstructured":"Twardella D, Brenner H. Effects of practitioner education, practitioner payment and reimbursement of patients' drug costs on smoking cessation in primary care: a cluster randomised trial. Tob Control. 2007;16(1):15\u201321.","journal-title":"Tob Control"},{"issue":"4","key":"1050_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/pds.2350","volume":"21","author":"JC Munson","year":"2012","unstructured":"Munson JC, Wahl PM, Daniel G, Kimmel SE, Hennessy S. Factors associated with the initiation of proton pump inhibitors in corticosteroid users. Pharmacoepidemiol Drug Saf. 2012;21(4):366\u201374.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1050_CR23","volume-title":"National Clinical Guideline for Care and Management in Adults","author":"National Collaborating Centre for Chronic Conditions (UK)","year":"2008","unstructured":"National Collaborating Centre for Chronic Conditions (UK). Osteoarthritis. In: National Clinical Guideline for Care and Management in Adults. London: Royal College of Physicians (UK); 2008."},{"issue":"8","key":"1050_CR24","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1007\/s10620-015-3642-8","volume":"60","author":"OB Kelly","year":"2015","unstructured":"Kelly OB, Dillane C, Patchett SE, Harewood GC, Murray FE. The inappropriate prescription of Oral proton pump inhibitors in the hospital setting: a prospective cross-sectional study. Dig Dis Sci. 2015;60(8):2280\u20136.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"1050_CR25","first-page":"326","volume":"107","author":"N Moran","year":"2014","unstructured":"Moran N, Jones E, O'Toole A, Murray F. The appropriateness of a proton pump inhibitor prescription. Ir Med J. 2014;107(10):326\u20137.","journal-title":"Ir Med J"},{"issue":"6","key":"1050_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/fampra\/cmu050","volume":"31","author":"P Haastrup","year":"2014","unstructured":"Haastrup P, Paulsen MS, Begtrup LM, Hansen JM, Jarb\u00f8l DE. Strategies for discontinuation of proton pump inhibitors: a systematic review. Fam Pract. 2014;31(6):625\u201330.","journal-title":"Fam Pract"},{"issue":"1","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1060028014558290","volume":"49","author":"E Reeve","year":"2015","unstructured":"Reeve E, Andrews JM, Wiese MD, Hendrix I, Roberts MS, Shakib S. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Ann Pharmacother. 2015;49(1):29\u201338.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00019053-200220030-00001","volume":"20","author":"KL Lapane","year":"2002","unstructured":"Lapane KL, Hughes CM. Optimising drug utilisation in long term care. Pharmacoeconomics. 2002;20(3):143\u201352.","journal-title":"Pharmacoeconomics."},{"issue":"5","key":"1050_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/0142159042000218669","volume":"26","author":"M Labelle","year":"2004","unstructured":"Labelle M, Beaulieu M, Paquette D, Fournier C, Bessette L, Choquette D, et al. An integrated approach to improving appropriate use of anti-inflammatory medication in the treatment of osteoarthritis in Qu\u00e9bec (Canada): the CURATA model. Med Teach. 2004;26(5):463\u201370.","journal-title":"Med Teach"},{"key":"1050_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1748-5908-7-24","volume":"7","author":"T Dreischulte","year":"2012","unstructured":"Dreischulte T, Grant A, Donnan P, McCowan C, Davey P, Petrie D, et al. A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary medical care: the DQIP study protocol. Implement Sci. 2012;7:24.","journal-title":"Implement Sci"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-019-1050-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12875-019-1050-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-019-1050-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T03:03:01Z","timestamp":1575601381000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-019-1050-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1186\/s12875-019-1050-4","relation":{},"ISSN":["1471-2296"],"issn-type":[{"type":"electronic","value":"1471-2296"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"26 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the province of Reggio Emilia. The Ethics Committee exempted the study from obtaining informed consent from the patients since the object of the study was not a new treatment. All GPs signed an informed consent to participate in the study.Trial number: NCT02691754 (Approved February 24, 2016). The Reggio Emilia public health primary care service treats the personal data of the subjects participating in the trial as an independent Data Controller, in accordance with the European legislation referred to in the GDPR 679\/2016 and, as provided for, of Legislative Decree 196\/2003.Primary care service is the owner of the data collected in clinical practice and for the use of personal and sensitive data of patients for research purposes. According to Italian legislation (at the time of the study the Legislative Decree 196\/2003), GPs have to obtain written consent to process data and personal information from his beneficiaries in order to receive the results of prescribed tests and other selected information from eventual hospital admissions, absence of this consent is a very rare conditions and implicitly would determine the exclusion of the patient from the study, since the GP could not include these patients in the osteoarthritic lists. The consent to participate in the study is provided by GP\u2019s, since it is the GP to be randomized.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}